Predicting Rupture of AAA by Anatomic and Hemodynamic Markers
Predicting Rupture of Abdominal Aortic Aneurysm (AAA) by Anatomic and Hemodynamic Markers From In-vivo and In-vitro Imaging
1 other identifier
observational
2
1 country
1
Brief Summary
The purpose of the study is to investigate imaging findings, which can help us to predict factors contributing to abdominal aortic aneurysm growth and rupture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2015
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2015
CompletedFirst Posted
Study publicly available on registry
June 4, 2015
CompletedStudy Start
First participant enrolled
August 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 14, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 14, 2022
CompletedMarch 18, 2022
March 1, 2022
6.5 years
June 2, 2015
March 17, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Imaging findings correlating with abdominal aortic aneurysm growth and rupture
1 year
Interventions
Eligibility Criteria
Primary and specialty care clinics and emergency room visits.
You may qualify if:
- Individuals between 18 and 80 years old receiving medical care at University of Minnesota Medical Center who have a normal aorta CTA within the previous year
- Or patients with known AAA with growth rate of 0-0.2 cm/year
- Or patients with known AAA with growth rate of greater than 0.5 cm/year.
You may not qualify if:
- Subjects with ferromagnetic implants
- Penile implant
- Hip replacement
- History of shrapnel or shot gun injury
- Body mass index ≥ 30
- Cardiac pacemakers
- Severe claustrophobia
- Large tattoos on the torso
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Minnesota
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Rosenberg, MD
University of Minnesota
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2015
First Posted
June 4, 2015
Study Start
August 1, 2015
Primary Completion
February 14, 2022
Study Completion
February 14, 2022
Last Updated
March 18, 2022
Record last verified: 2022-03